These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15682577)

  • 1. A new approach to the treatment of osteoporosis.
    Erdemli B; Serin-Kiliçoglu S; Erdemli E
    Orthopedics; 2005 Jan; 28(1):59-62. PubMed ID: 15682577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and bone formation.
    Garrett IR; Gutierrez G; Mundy GR
    Curr Pharm Des; 2001 May; 7(8):715-36. PubMed ID: 11405194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of simvastatin on the differentiation of marrow stromal cells from aging rats.
    Liu M; Wang K; Tang T; Dai K; Zhu Z
    Pharmazie; 2009 Jan; 64(1):43-8. PubMed ID: 19216230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of beta-hydroxy-beta-methylglutaryl coenzyme A reductase decreases energy supply to the myocardium in rats.
    Pisarenko OI; Studneva IM; Lankin VZ; Konovalova GG; Tikhaze AK; Kaminnaya VI; Belenkov YN
    Bull Exp Biol Med; 2001 Oct; 132(4):956-8. PubMed ID: 11782791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
    Yang SH; Choi JS; Choi DH
    Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA.
    Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB
    Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of simvastatin with aromasin in an ovariectomized rat model: effects on the skeletal system.
    Chen SH; Chou FF; Ko JY
    Chang Gung Med J; 2010; 33(5):509-14. PubMed ID: 20979701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New addition to the statin's effect.
    Serin-Kilicoglu S; Erdemli E
    J Trauma; 2007 Jul; 63(1):187-91. PubMed ID: 17622888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcyclin, a Ca2+ ion-binding protein, contributes to the anabolic effects of simvastatin on bone.
    Hwang R; Lee EJ; Kim MH; Li SZ; Jin YJ; Rhee Y; Kim YM; Lim SK
    J Biol Chem; 2004 May; 279(20):21239-47. PubMed ID: 14973129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
    Maeda T; Matsunuma A; Kawane T; Horiuchi N
    Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
    Alberts AW
    Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats.
    Hooiveld GJ; Vos TA; Scheffer GL; Van Goor H; Koning H; Bloks V; Loot AE; Meijer DK; Jansen PL; Kuipers F; Müller M
    Gastroenterology; 1999 Sep; 117(3):678-87. PubMed ID: 10464145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
    Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
    Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy.
    Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity.
    Staal A; Frith JC; French MH; Swartz J; Güngör T; Harrity TW; Tamasi J; Rogers MJ; Feyen JH
    J Bone Miner Res; 2003 Jan; 18(1):88-96. PubMed ID: 12510809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin inhibits cardiac hypertrophy and angiotensin-converting enzyme activity in rats with aortic stenosis.
    Luo JD; Zhang WW; Zhang GP; Guan JX; Chen X
    Clin Exp Pharmacol Physiol; 1999 Nov; 26(11):903-8. PubMed ID: 10561812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats.
    Pruefer D; Scalia R; Lefer AM
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2894-900. PubMed ID: 10591666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins-Their Role in Bone Tissue Metabolism and Local Applications with Different Carriers.
    Granat MM; Eifler-Zydel J; Kolmas J
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against osteoporosis by statins is linked to a reduction of oxidative stress and restoration of nitric oxide formation in aged and ovariectomized rats.
    Yin H; Shi ZG; Yu YS; Hu J; Wang R; Luan ZP; Guo DH
    Eur J Pharmacol; 2012 Jan; 674(2-3):200-6. PubMed ID: 22130356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.